Mammalian
atria have previously been shown to produce a variety of peptides with natriuretic and vasorelaxant activities.
Certain of these atrial natriuretic factors (ANF) have been localized immunocytochemically in secretory granules of atnial myocytes.
However, the precise sites of action and extra-atrial synthesis or accumulation of ANF have not been identified immunocytochemically.
In the present study, immunoreactive ANF was detected in rat atrial myocytes, intercalated cells of the renal collecting ducts, adrenal medullary chromaffin cells, and gonadotrophs of the anterior pituitary using an antibody against synthetic rat ANF-IV (H2N-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Ang-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Try-COOH).
The localization of ANF in Introduction Atrial natriuretic factors (ANF) are a family of peptides with potent natriuretic (deBold et al., 1981; Borenstein et al., 1983) and vasorelaxant activities (Grammer et al., 1983; Kleinert et al., 1984) . The presence of ANF in specific granules of atrial myocytes has been demonstrated immunocytochemically (Cantin et al., 1984) . However, with the exception of rat salivary glands (Cantin et al., 1984) , H2O status have previously been shown to affect both the atrial granularity (deBold, 1979) and atnial ANF content (Pollock and Banks, , 1981; Pollock and Banks, 1983) . A site of action within the nephron/cohlecting duct system is further supported by the similarity ofrenal action ofthe diuretic furosemide to ANF (Sonnenberg, 1978) and by an apparent requirement for proximal tubular organic acid transport for maximal ANF activity (Sonnenberg et al., 198 la) . Studies using the techniques of micropuncture, microcathetenization, and distal blockage (Sonnenberg et al., 1981b; Bniggs et al., 1982; Pollock and Banks, 1983) 
